CA AB804

Adds confidentiality protection for pharmacy invoice information submitted to establish average acquisition costs for Medi-Cal drug reimbursement, exempting it from public disclosure under the California Public Records Act.

Requires Medi-Cal pharmacy providers to submit drug price information including invoice prices, discounts, rebates, and refunds to the department or designated vendor for establishing average acquisition costs.

Establishes that pharmacy invoice information is confidential while keeping the calculated average acquisition cost itself subject to public disclosure.

Includes legislative findings demonstrating the constitutional necessity for protecting pharmacy provider privacy when disclosing sensitive pricing information.

Applies confidentiality protection specifically to invoice data submitted for purposes of establishing average acquisition costs under the Medi-Cal reimbursement methodology.